Qyuns Therapeutics(02509)
Search documents
荃信生物-B(02509.HK)1月14日耗资61.8万港元回购2.72万股
Ge Long Hui· 2026-01-14 14:17
格隆汇1月14日丨荃信生物-B(02509.HK)公告,1月14日耗资61.8万港元回购2.72万股。 ...
荃信生物-B1月14日斥资61.8万港元回购2.72万股
Zhi Tong Cai Jing· 2026-01-14 14:17
荃信生物-B(02509)发布公告,于2026年1月14日,该公司斥资约61.8万港元回购2.72万股股份,每股回 购价格为22.54-22.88港元。 ...
荃信生物-B(02509)1月14日斥资61.8万港元回购2.72万股
智通财经网· 2026-01-14 14:13
智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月14日,该公司斥资约61.8万港元回购2.72万 股股份,每股回购价格为22.54-22.88港元。 ...
荃信生物(02509) - 翌日披露报表
2026-01-14 14:08
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) FF305 確認 不適用 表格類別: 股票 狀態: 新提交 公司名稱: 江蘇荃信生物醫藥股份有限公司 呈交日期: 2026年1月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02509 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | 已發行股份總數 | | 事件 | | 已發行股份(不包括庫存股份)數 目 ...
智通港股回购统计|1月14日





智通财经网· 2026-01-14 01:41
Group 1 - The article discusses the share buybacks conducted by various companies on January 13, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.012 million shares [1][2] - Other notable companies involved in the buyback include Xiaomi Group (01810) with 4 million shares repurchased for 152 million yuan, and Sunny Optical Technology (02382) with 640,000 shares for approximately 41.79 million yuan [1][2] - The total number of shares repurchased by Tencent Holdings in the year reached 11 million, representing 1.199% of its total share capital [2] Group 2 - The buyback activities reflect a strategic move by companies to enhance shareholder value and signal confidence in their financial health [1][2] - Companies like Weigao Group (01066) and Xinli International (00732) also showed significant buyback activity, with Weigao repurchasing 27,440 shares for 1.4962 million yuan, representing 6.519% of its total share capital [2] - The data indicates a trend among companies to engage in share buybacks as a method to return capital to shareholders and potentially boost stock prices [1][2][3]
荃信生物-B(02509.HK)1月13日耗资63.6万港元回购2.84万股
Ge Long Hui· 2026-01-13 13:25
格隆汇1月13日丨荃信生物-B(02509.HK)公告,1月13日耗资63.6万港元回购2.84万股。 ...
荃信生物-B1月13日斥资63.62万港元回购2.84万股
Zhi Tong Cai Jing· 2026-01-13 13:18
荃信生物-B(02509)发布公告,于2026年1月13日,该公司斥资63.62万港元回购2.84万股股份,每股回购 价22.4港元。 ...
荃信生物-B(02509)1月13日斥资63.62万港元回购2.84万股
智通财经网· 2026-01-13 13:17
智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月13日,该公司斥资63.62万港元回购2.84万 股股份,每股回购价22.4港元。 ...
荃信生物(02509) - 翌日披露报表
2026-01-13 13:10
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 江蘇荃信生物醫藥股份有限公司 呈交日期: 2026年1月13日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02509 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | 事件 | 已發行股份(不包括庫存股份)數 目 ...
智通港股回购统计|1月13日
智通财经网· 2026-01-13 01:12
Group 1 - The article reports on share buybacks conducted by various companies on January 12, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.024 million shares [1][2] - Other notable companies involved in the buyback include Geely Automobile (00175) with 9.007 million shares repurchased for 151 million yuan, and Sunny Optical Technology (02382) with 1.24 million shares for 79.34 million yuan [1][2] - The total number of shares repurchased by Tencent represents 1.188% of its total share capital, while Geely's buyback accounts for 0.438% of its total share capital [2] Group 2 - The buyback activities reflect a trend among companies to return capital to shareholders, with some companies like Antong Oilfield Services (03337) and Weigao Group (01066) showing significant percentages of their total share capital being repurchased, at 2.460% and 6.459% respectively [2][3] - Companies such as Vitasoy International (00345) and Keep (03650) also participated in the buyback, with their repurchase amounts being 432,600 yuan and 28,900 yuan respectively, indicating a diverse range of companies engaging in this practice [3] - The data suggests a strategic move by these companies to enhance shareholder value and potentially stabilize their stock prices amid market fluctuations [1][2]